Search for: "Eli Lilly "
Results 341 - 360
of 2,147
Sort by Relevance
|
Sort by Date
5 Jul 2018, 7:20 am
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
3 Jul 2018, 10:21 am
More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post Actavis UK Limited v Eli Lilly, Supreme Court of the United Kingdom, [2017] UKSC 48, 12 July 2017 appeared first on Kluwer Patent Blog. [read post]
28 Jun 2018, 2:45 am
Sara MoranFollowing its denial of Actavis’ claim for declarations of non-infringement in respect of Eli Lilly’s European Patent, the Court of Appeal ruled on a number of procedural matters arising from that judgment. [read post]
27 Jun 2018, 7:24 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) | Book review: Propertizing European Copyright – History, Challenges and Opportunities | GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial… [read post]
25 Jun 2018, 7:15 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) | Book review: Propertizing European Copyright – History, Challenges and Opportunities | GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial… [read post]
22 Jun 2018, 3:18 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) | Book review: Propertizing European Copyright – History, Challenges and Opportunities | GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial designs… [read post]
21 Jun 2018, 12:50 pm
Eli Lilly & Co. v. [read post]
Seventh Circuit Upholds Preliminary Injunction Issued in Favor of Elanco US, Inc. Against Arla Foods
21 Jun 2018, 8:02 am
Eli Lilly & Company and its subsidiary, Elanco US Inc., both of Greenfield, Indiana, filed suit in the Eastern District of Wisconsin alleging that Arla Foods, Inc. [read post]
21 Jun 2018, 8:02 am
Eli Lilly & Company and its subsidiary, Elanco US Inc., both of Greenfield, Indiana, filed suit in the Eastern District of Wisconsin alleging that Arla Foods, Inc. [read post]
20 Jun 2018, 4:12 am
C-322/10 – Medeva, C-518/10 – Yeda, C-630/10 – University of Queensland, C-6/11 – Daiichi Sankyo, C-493/12 – Eli Lilly, and C-443/12 – Actavis/Sanofi) and came to the conclusion that the requirements of Article 3(a) of the EU SPC-Regulation No 469/2009, i.e. whether the product of an SPC is protected by the basic patent, are unclear and, therefore, there was no reason to move away from the infringement test. [read post]
4 Jun 2018, 3:02 am
Image credits: Sleepwalking - GIPHYAmsterdam - Shovy Rahman PREVIOUSLY ON NEVER TOO LATENever Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial designs | Decoding the Scope of Patent Protection: Singapore after Eli Lilly v. [read post]
1 Jun 2018, 12:13 pm
Eli Lilly & Co. v. [read post]
31 May 2018, 6:25 am
Pharmaceutical maker “Eli Lilly, referring to two popular antidepressants, said in a statement the company ‘remains committed to Prozac [fluoxetine] and Cymbalta [duloxetine] and their safety and benefits, which have been repeatedly affirmed by the US Food and Drug Administration. [read post]
28 May 2018, 7:53 am
Eli Lilly pemetrexed battles here, here and here. [read post]
21 May 2018, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
18 May 2018, 5:25 am
Eli Lilly& Co., 598 F.3d 1336, 1351 (Fed. [read post]
17 May 2018, 1:36 pm
Having presided over major decisions impacting both on IP law and practice, not the least Actavis v Eli Lilly, Baron Neuberger will be sharing his insights and reflections on “IP in the UK and Europe – a view from the top”. [read post]
14 May 2018, 12:30 pm
Birss would not be drawn on his views of the Supreme Court's decision in Eli Lilly v Actavis (see the IPKat here - the 109 comments on the post is a good indication of how controversial this decision has been). [read post]
10 May 2018, 11:12 pm
The UK Supreme Court's decision in Eli Lilly v. [read post]
6 Apr 2018, 8:03 am
The Court of Appeal heard arguments regarding whether, if they had accepted Kymab's construction of "in situ replacement", they could nevertheless have found infringement on the basis of Actavis v Eli Lilly (Eli Lilly v Actavis UK [2017] UKSC 48, IPKat post). [read post]
